Trialant
Platform
  • Home
  • Studies
Other
  • Terms of Service
  • Privacy Policy
  1. Studies

Overview

Key facts that identify this study and show where it stands today.

Description

What the study is about and why it is being run, in the researchers' own words.

Conditions

The medical conditions and diseases this study investigates.

Interventions

The treatments and procedures being evaluated in this study.

Participation

Who can join this study and the criteria used to decide.

Design

How the study is designed and how its participant groups are organized.

Contacts

The people to reach with questions about this study or how to join it.

Locations

Where the study is run and whether each site is currently recruiting.

Collaborators

The organizations and people involved in this study.

Similar Studies

Other registered studies that closely resemble this one.

On this page

  • Overview
  • Description
  • Conditions
  • Interventions
  • Participation
  • Design
  • Contacts
  • Locations
  • Collaborators
  • Similar Studies
Workspace
Home
Studies
  • Terms of Service
    Privacy Policy
    Sign up
    NCT00826020
    • Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
      NCT01845116
      CompletedInterventionalPhase 2Updated Nov 23, 2022
    • Omegaven® as Parenteral Nutrition
      NCT02334293
      Unknown statusInterventionalNot ApplicableUpdated Jan 8, 2015
    • Cholestasis Reversal: Efficacy of IV Fish Oil
      NCT00910104
      CompletedInterventionalPhase 2Phase 3Updated Sep 19, 2024
    • Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
      NCT04697888
      CompletedInterventionalPhase 2Phase 3Updated Jun 11, 2021
    • Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
      NCT00862446
      CompletedInterventionalPhase 4Updated Jan 5, 2021
    • Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
      NCT01089426
      CompletedInterventionalNot ApplicableUpdated May 6, 2019